USA – The FDA has approved two once-daily, oral JAK inhibitors on for patients with moderate-to-severe atopic dermatitis whose disease is not well controlled with other systemic medications, including biologics,…
Read MoreAbbVie, Pfizer’s JAK inhibitors get FDA clearance to treat atopic dermatitis
